ARCA biopharma (ABIO) Short Interest Ratio & Short Volume → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free ABIO Stock Alerts $3.36 +0.07 (+2.13%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ARCA biopharma Short Interest DataCurrent Short Volume5,660,000 sharesPrevious Short Volume195,700 sharesChange Vs. Previous Month+2,792.18%Dollar Volume Sold Short$18.00 millionShort Interest Ratio / Days to Cover4.1Last Record DateApril 15, 2024Outstanding Shares14,507,000 sharesFloat Size14,310,000 sharesShort Percent of Float39.55%Today's Trading Volume40,419 sharesAverage Trading Volume1,021,796 sharesToday's Volume Vs. Average4% Short Selling ARCA biopharma ? Sign up to receive the latest short interest report for ARCA biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatABIO Short Interest Over TimeABIO Days to Cover Over TimeABIO Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself ARCA biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20245,660,000 shares $18.00 million +2,792.2%39.6%4.1 $3.18 3/31/2024195,700 shares $344,432.00 +6.6%1.4%0.1 $1.76 3/15/2024183,600 shares $310,284.00 +0.7%1.3%6.3 $1.69 2/29/2024182,300 shares $297,149.00 -1.9%1.3%6.9 $1.63 2/15/2024185,900 shares $306,735.00 -1.2%1.3%7.2 $1.65 1/31/2024188,100 shares $299,079.00 -3.3%1.3%7.5 $1.59 Get the Latest News and Ratings for ABIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024194,600 shares $317,198.00 -0.4%1.4%7.7 $1.63 12/31/2023195,400 shares $332,180.00 -7.9%1.4%8 $1.70 12/15/2023212,200 shares $371,350.00 +3.9%1.5%9.1 $1.75 11/30/2023204,300 shares $371,826.00 -4.7%1.4%9.5 $1.82 11/15/2023214,400 shares $375,200.00 -2.6%1.5%9.4 $1.75 10/31/2023220,100 shares $391,778.00 -9.8%1.6%9.6 $1.78 10/15/2023243,900 shares $496,336.50 +3.8%1.7%11.6 $2.04 9/30/2023234,900 shares $472,149.00 -11.4%1.7%11.9 $2.01 9/15/2023265,000 shares $543,250.00 +9.5%1.9%12.9 $2.05 8/31/2023242,000 shares $496,100.00 -7.0%1.7%10.5 $2.05 8/15/2023260,300 shares $531,012.00 +2.4%1.8%10.6 $2.04 7/31/2023254,300 shares $518,772.00 -4.0%1.8%10.2 $2.04 7/15/2023264,800 shares $534,896.00 -2.9%1.9%9.9 $2.02 6/30/2023272,700 shares $553,581.00 -1.2%1.9%10.6 $2.03 6/15/2023276,100 shares $579,810.00 +1.3%1.9%10 $2.10 5/31/2023272,600 shares $575,186.00 +0.6%1.9%10.6 $2.11 5/15/2023270,900 shares $560,763.00 +1.6%1.9%11.1 $2.07 4/30/2023266,600 shares $533,200.00 +8.7%1.9%11.1 $2.00 4/15/2023245,200 shares $490,890.40 -12.6%1.7%10.2 $2.00 3/31/2023280,400 shares $557,996.00 +23.9%2.0%9.7 $1.99 3/15/2023226,300 shares $491,071.00 -7.1%1.6%5.8 $2.17 2/28/2023243,500 shares $535,700.00 -2.2%1.7%6.3 $2.20 2/15/2023248,900 shares $522,690.00 -3.8%1.8%6.6 $2.10 1/31/2023258,600 shares $568,920.00 -9.0%1.8%6.7 $2.20 1/15/2023284,300 shares $666,683.50 -51.1%2.0%7.4 $2.35 12/30/2022581,500 shares $1.38 million +1,022.6%4.1%16.9 $2.37 12/15/202251,800 shares $120,176.00 -3.2%0.4%1.8 $2.32 11/30/202253,500 shares $111,815.00 +5.9%0.4%2 $2.09 11/15/202250,500 shares $101,000.00 -0.8%0.4%1.7 $2.00 10/31/202250,900 shares $109,435.00 -8.6%0.4%1.7 $2.15 10/15/202255,700 shares $114,185.00 -4.5%0.4%1.7 $2.05 9/30/202258,300 shares $120,098.00 -26.9%0.4%1.7 $2.06 9/15/202279,700 shares $186,498.00 +47.6%0.6%2 $2.34 8/31/202254,000 shares $126,360.00 -4.1%0.4%1.4 $2.34AI “wealth window” is closing June 25th (Ad)Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… ABIO Short Interest - Frequently Asked Questions What is ARCA biopharma's current short interest? Short interest is the volume of ARCA biopharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 5,660,000 shares of ABIO short. 39.55% of ARCA biopharma's shares are currently sold short. Learn More on ARCA biopharma's current short interest. What is a good short interest ratio for ARCA biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABIO shares currently have a short interest ratio of 4.0. Learn More on ARCA biopharma's short interest ratio. Which institutional investors are shorting ARCA biopharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ARCA biopharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ARCA biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 39.55% of ARCA biopharma's floating shares are currently sold short. Is ARCA biopharma's short interest increasing or decreasing? ARCA biopharma saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 5,660,000 shares, an increase of 2,792.2% from the previous total of 195,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ARCA biopharma's float size? ARCA biopharma currently has issued a total of 14,507,000 shares. Some of ARCA biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ARCA biopharma currently has a public float of 14,310,000 shares. How does ARCA biopharma's short interest compare to its competitors? 39.55% of ARCA biopharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to ARCA biopharma: ImmuCell Co. (0.08%), Aspira Women's Health Inc. (2.52%), OncoCyte Co. (3.08%), Alpha Teknova, Inc. (0.45%), Cardio Diagnostics Holdings, Inc. (2.91%), Trinity Biotech plc (0.03%), Achieve Life Sciences, Inc. (2.08%), Rockwell Medical, Inc. (2.40%), DarioHealth Corp. (4.65%), HCW Biologics Inc. (0.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short ARCA biopharma stock? Short selling ABIO is an investing strategy that aims to generate trading profit from ARCA biopharma as its price is falling. ABIO shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ARCA biopharma? A short squeeze for ARCA biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABIO, which in turn drives the price of the stock up even further. How often is ARCA biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABIO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ImmuCell Short Interest Aspira Women's Health Short Interest OncoCyte Short Interest Alpha Teknova Short Interest Cardio Diagnostics Short Interest Trinity Biotech Short Interest Achieve Life Sciences Short Interest Rockwell Medical Short Interest DarioHealth Short Interest HCW Biologics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ABIO) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders